Navigating the Confluence of Metabolic Dysfunction, Alcohol Use, and Advanced Liver Disease

Through interactive expert discussion, Drs. Noureddin, Loomba, and Mellinger will explore the advanced liver disease continuum and prognostic importance of fibrosis, review metabolic drivers and the role of alcohol in advanced liver disease progression, and highlight patient-centered approaches to integrated AUD and ALD care.

Industry Supporter: Altimmune